查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600530

生物製药辅料市场：按产品、特性、应用和最终用户 - 2025-2030 年全球预测

Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药辅料市场价值为22.9亿美元，预计2024年将达到25.3亿美元，复合年增长率为10.75%，到2030年将达到47亿美元。

生物製药辅料是与药品活性成分结合，作为载体，提高药品稳定性、吸收性和可製造性的惰性物质。它在锭剂、胶囊和注射剂等药物製剂中发挥着至关重要的作用。市场范围涵盖口服、局部和肠胃外製剂等各种最终用途。由于人口老化和慢性病的盛行率增加，对生物製药的需求不断增加，强调需要先进的赋形剂解决方案来提高药物疗效和患者依从性。一个关键的市场成长要素是药物输送系统不断增长的技术创新，为公司提供了开发多功能辅料以满足特定医疗需求的机会。由于蛋白质和胜肽药物客製化赋形剂的重要性，生技药品和生物相似药市场的扩张进一步推动了需求。根据监管标准和环境考虑，存在开发永续且无害的多功能辅料的机会。然而，市场面临严格的监管要求和开发新辅料的高成本等挑战。此外，潜在的赋形剂-药物交互作用和品管问题可能是一个限制。为了实现成长，公司应专注于探索生物相容性和高效的运载工具，包括探索符合绿色化学原则的基于天然聚合物的选择。这可能会带来解决安全和环境问题并提高市场竞争力的突破。市场格局是动态的，公司之间的整合不断增加，以释放协同效应并增强研发能力。透过新颖的化学结构和先进的製造技术（例如奈米技术）进行创新对于满足复杂的配方需求至关重要。透过利用这些机会并应对相关挑战，公司可以促进生物製药辅料市场的成长，同时培养永续和强大的创新解决方案管道。

主要市场统计
基准年[2023] 22.9亿美元
预测年份 [2024] 25.3亿美元
预测年份 [2030] 47亿美元
复合年增长率（%） 10.75%

市场动态：快速发展的生物製药辅料市场的关键市场洞察

供需的动态交互作用正在改变生物製药辅料市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对先进功能性生物製药配方的需求不断增长
    • 大分子开发的需求不断增加
    • 增加生物相似药的开发
    • 对荷尔蒙疗法和基因治疗的需求增加
    • 全球疫苗量产
  • 市场限制因素
    • 生物製药辅料价格高
  • 市场机会
    • 生技药品製造外包的新趋势
    • 功能性添加剂的需求显着增加
    • 重组DNA技术的发展
  • 市场挑战
    • 製造复杂性和生物製药辅料污染问题
    • 生物製药耗时的临床试验

波特五力：驾驭生物製药辅料市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物製药辅料市场的外部影响

外部宏观环境因素在塑造生物製药辅料市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物製药辅料市场竞争状况

对生物製药辅料市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物製药辅料市场供应商绩效评估

FPNV定位矩阵是评估生物製药辅料市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对先进功能性生物製药配方的需求不断增长
      • 对聚合物开发的需求不断增加
      • 增加生物相似药的开发
      • 对荷尔蒙和基因治疗的需求增加
      • 全球疫苗大规模生产
    • 抑制因素
      • 生物製药辅料价格高
    • 机会
      • 生物製药製造外包新趋势
      • 功能性添加剂需求大幅增加
      • 重组DNA技术的发展
    • 任务
      • 生物製药辅料製造的复杂性与污染问题
      • 生物製药耗时的临床试验
  • 市场区隔分析
    • 产品：碳水化合物是药物製剂中用来确保製剂稳定性和患者依从性的主要赋形剂。
    • 功能：提高防腐剂利用率并提高生物製药的稳定性
    • 应用：生物製药辅料在先进的药物控制释放输送系统中的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章生物製药辅料市场：副产品

  • 碳水化合物
    • 葡萄糖
    • 淀粉
    • 蔗糖
  • 多元醇
    • 甘露醇
    • 山梨醇
  • 增溶剂和界面活性剂/乳化剂
    • 酯
    • 三酸甘油酯
  • 特殊添加物

第七章生物製药辅料市场：依功能

  • 活页夹
  • 涂层
  • 崩坏
  • 润滑剂和润滑剂
  • 药用填充剂
  • 防腐剂

第八章生物製药辅料市场：依应用分类

  • 先进的输送系统
  • 口服
  • 胃肠外的
  • 话题

第九章生物製药辅料市场：依最终用户分类

  • 契约製造组织
  • 製药和生物技术公司

第十章美洲生物製药辅料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生物药辅料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲/中东/非洲生物药辅料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 罗盖特透过推出 PEARLITOL 200 INH 展示了生物製药辅料的创新。
    • 巴伦支海和亚什兰之间的战略协议加强了高纯度二聚体二糖辅料在美国生物製药市场的分销
    • Rocket推出三类食品补充保湿成分
    • Croda Pharma 开始兴建积层製造厂

公司名单

  • ABITEC Corporation
  • Actylis
  • Ashland Global Holdings Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon, Inc.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD NV
  • Innophos Holdings, Inc.
  • J. Rettenmaier & Sohne GmbH+Co KG
  • Meggle Group GmbH
  • Merck KGaA
  • Roquette Freres SA
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc.
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • VWR International, LLC by Avantor
  • Wacker Chemie AG
Product Code: MRR-A339DAEFAD78

The Biopharmaceutical Excipients Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.53 billion in 2024, and is projected to grow at a CAGR of 10.75%, to USD 4.70 billion by 2030.

Biopharmaceutical excipients are inactive substances formulated alongside the active ingredient in a medication, serving as carriers and enhancing the stability, absorption, and manufacturability of pharmaceuticals. They play a pivotal role in drug formulation, including tablets, capsules, and injectable products. The market scope encompasses various end-use applications, such as oral, topical, and parenteral delivery systems. Increasing demand for biopharmaceuticals, driven by an aging population and a rise in chronic disease prevalence, underscores the necessity for advanced excipient solutions that improve drug efficacy and patient compliance. A key market growth factor is the ongoing innovation in drug delivery systems, providing opportunities for companies to develop multifunctional excipients that cater to specific medical needs. The expansion of the biologics and biosimilars markets further propels demand, as excipients tailored for protein and peptide drugs are crucial. Opportunities exist in developing sustainable, non-toxic, and multifunctional excipients that align with regulatory standards and environmental considerations. However, the market faces challenges, such as stringent regulatory requirements and the high cost of developing novel excipients. Additionally, potential excipient-drug interactions and quality control issues may pose limitations. To thrive, companies should focus on research in biocompatible and efficient delivery excipients, including exploring natural polymer-based options which align with green chemistry principles. This could provide a breakthrough in addressing safety and environmental concerns, offering a competitive edge in the market. The market landscape is dynamic, with increasing consolidation among players to harness synergies and enhance R&D capabilities. Innovation is crucial, either through novel chemical structures or advanced manufacturing technologies, such as nanotechnology, to fulfill complex formulation needs. By capitalizing on these opportunities and addressing associated challenges, businesses can drive growth in the biopharmaceutical excipients market while fostering a sustainable and robust pipeline of innovative solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.29 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 4.70 billion
CAGR (%) 10.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Excipients Market

The Biopharmaceutical Excipients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
    • Increasing Need for Large-Molecule Development
    • Increasing Development of Biosimilars
    • Increasing Demand for Hormone and Gene Therapy
    • Bulk Vaccine Production Worldwide
  • Market Restraints
    • High Price of Biopharmaceutical Excipients
  • Market Opportunities
    • Emerging Trends of Outsourcing for the Production of Biologics
    • Substantial Rise in Need of Functional Excipients
    • Developments in Recombinant DNA Technologies
  • Market Challenges
    • Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
    • Time Consuming Biopharmaceutical Clinical Trials

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Excipients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Excipients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Excipients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Excipients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Excipients Market

A detailed market share analysis in the Biopharmaceutical Excipients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Excipients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Excipients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Sohne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Freres S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Specialty Excipients. The Carbohydrates is further studied across Dextrose, Starch, and Sucrose. The Polyols is further studied across Mannitol and Sorbitol. The Solubilizers & Surfactants/Emulsifiers is further studied across Esters and Triglycerides.
  • Based on Function, market is studied across Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers, and Preservatives.
  • Based on Application, market is studied across Advanced Delivery System, Oral, Parenteral, and Topical.
  • Based on End User, market is studied across Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • 5.1.1.2. Increasing Need for Large-Molecule Development
      • 5.1.1.3. Increasing Development of Biosimilars
      • 5.1.1.4. Increasing Demand for Hormone and Gene Therapy
      • 5.1.1.5. Bulk Vaccine Production Worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High Price of Biopharmaceutical Excipients
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
      • 5.1.3.2. Substantial Rise in Need of Functional Excipients
      • 5.1.3.3. Developments in Recombinant DNA Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • 5.1.4.2. Time Consuming Biopharmaceutical Clinical Trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • 5.2.2. Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • 5.2.3. Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Biopharmaceutical Excipients Market, by Product

  • 6.1. Introduction
  • 6.2. Carbohydrates
    • 6.2.1. Dextrose
    • 6.2.2. Starch
    • 6.2.3. Sucrose
  • 6.3. Polyols
    • 6.3.1. Mannitol
    • 6.3.2. Sorbitol
  • 6.4. Solubilizers & Surfactants/Emulsifiers
    • 6.4.1. Esters
    • 6.4.2. Triglycerides
  • 6.5. Specialty Excipients

7. Biopharmaceutical Excipients Market, by Function

  • 7.1. Introduction
  • 7.2. Binders
  • 7.3. Coatings
  • 7.4. Disintegrants
  • 7.5. Lubricants & glidants
  • 7.6. Pharmaceutical Fillers
  • 7.7. Preservatives

8. Biopharmaceutical Excipients Market, by Application

  • 8.1. Introduction
  • 8.2. Advanced Delivery System
  • 8.3. Oral
  • 8.4. Parenteral
  • 8.5. Topical

9. Biopharmaceutical Excipients Market, by End User

  • 9.1. Introduction
  • 9.2. Contract Manufacturing Organizations
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Biopharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biopharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biopharmaceutical Excipients Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Roquette showcases innovation in biopharmaceutical excipients with launch of PEARLITOL 200 INH
    • 13.3.2. Strategic agreement between Barentz and Ashland enhances distribution of high-purity Vialose excipient in the United States biopharmaceutical market
    • 13.3.3. Roquette launches three moisture-protecting ingredients for nutraceuticals
    • 13.3.4. Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Companies Mentioned

  • 1. ABITEC Corporation
  • 2. Actylis
  • 3. Ashland Global Holdings Inc.
  • 4. BASF SE
  • 5. Clariant International Ltd.
  • 6. Colorcon, Inc.
  • 7. Croda International PLC
  • 8. DFE Pharma GmbH & Co KG
  • 9. Eastman Chemical Company
  • 10. Evonik Industries AG
  • 11. Fuji Chemical Industries Co., Ltd.
  • 12. IMCD N.V.
  • 13. Innophos Holdings, Inc.
  • 14. J. Rettenmaier & Sohne GmbH + Co KG
  • 15. Meggle Group GmbH
  • 16. Merck KGaA
  • 17. Roquette Freres S.A.
  • 18. Sigachi Industries Limited
  • 19. Spectrum Laboratory Products, Inc.
  • 20. SPI Pharma, Inc.
  • 21. The Dow Chemical Company
  • 22. The Lubrizol Corporation
  • 23. VWR International, LLC by Avantor
  • 24. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARK